Project Details
Projekt Print View

Identification of epilepsy genes through family studies in the Middle East

Subject Area Molecular and Cellular Neurology and Neuropathology
Term from 2014 to 2019
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 245609332
 
Final Report Year 2019

Final Report Abstract

In summary, the current project performed genetic studies in 119 families affected by epilepsy and neurodevelopmental disorders in Israel and Palestine, including 873 individuals. We identified a monogenic cause in 16/119 families (13,4%), a percentage that was lower than typically seen in large family studies where the diagnostic yield may be up to 30%. Only two genes (SCN1A, KCNQ2) were seen as causative genetic etiologies in more than one family, underlining the genetic heterogeneity in this cohort. Polygenic risk scores failed to translate into our study cohort given the population differences, suggesting that novel strategies are required to assess the contribution of common genetic variants in small pedigrees. Taking together, more than 80% of the familial risk of epilepsy remains unexplained despite state-of-the-art genetic analysis, including analysis of novel genetic etiologies in some individuals. Several novel genetic etiologies including KCNB1, ARHGEF9, and NPRL3 were supported by finding in our current cohort. Our study highlights the role of known monogenic causes in familial epilepsies, emphasizes the need for ongoing gene discovery, and indicates a persisting major gap in explaining the familial risk for epilepsies, even in the presence of genomic information. We aim to extend our studies to include novel methods to analysis complex genetic contributions in families including computational methods for genotype-phenotype correlations, and apply novel genetic analysis techniques including genome sequencing and repeat expansions in the continuation of the current project.

Publications

  • Mutations in the GABA Transporter SLC6A1 Cause Epilepsy with Myoclonic-Atonic Seizures. Am J Hum Genet 2015;96:808-15
    Carvill GL, McMahon JM, …; EuroEPINOMICS Rare Epilepsy Syndrome Myoclonic-Astatic Epilepsy & Dravet working group, Helbig I, Striano P, Weckhuysen S, Berkovic SF, Scheffer IE, Mefford HC
    (See online at https://doi.org/10.1016/j.ajhg.2015.02.016)
  • The role of SLC2A1 mutations in myoclonic astatic epilepsy and absence epilepsy, and the estimated frequency of GLUT1 deficiency syndrome. Epilepsia 2015;56:e203-8
    Larsen J, Johannesen KM, …; MAE working group of EuroEPINOMICS RES Consortium, …, Helbig I, Møller RS
    (See online at https://doi.org/10.1111/epi.13222)
  • A recurrent mutation in KCNA2 as a novel cause of hereditary spastic paraplegia and ataxia. Ann Neurol. 2016 Oct;80(4)
    Helbig KL, Hedrich UB, …, Helbig I, Lerche H, Lemke JR
    (See online at https://doi.org/10.1002/ana.24762)
  • Autosomal dominant epilepsy with auditory features: a new LGI1 family including a phenocopy with cortical dysplasia. J Neurol. 2016 Jan;263(1):11-6
    Klein KM, Pendziwiat M, …, Afawi Z, Helbig I
    (See online at https://doi.org/10.1007/s00415-015-7921-2)
  • Rare Noncoding Mutations Extend the Mutational Spectrum in the PGAP3 Subtype of Hyperphosphatasia with Mental Retardation Syndrome. Hum Mutat. 2016 Aug;37(8):737-44
    Knaus A, Awaya T, Helbig I, Afawi Z, Pendziwiat M, …, Krawitz PM
    (See online at https://doi.org/10.1002/humu.23006)
  • Seizures as presenting and prominent symptom in chorea-acanthocytosis with c.2343del VPS13A gene mutation. Epilepsia. 2016 Apr;57(4):549-56
    Benninger F, Afawi Z, Korczyn AD, …, Helbig I, Berkovic SF, Blatt I
    (See online at https://doi.org/10.1111/epi.13318)
  • Clinical spectrum and genotype-phenotype associations of KCNA2-related encephalopathies. Brain. 2017 Sep 1;140(9):2337-2354
    Masnada S, Hedrich UBS, …, Helbig I, …, Rubboli G
    (See online at https://doi.org/10.1093/brain/awx184)
  • Neurodevelopmental Disorders Caused by De Novo Variants in KCNB1 Genotypes and Phenotypes. JAMA Neurol. 2017 Oct 1;74(10):1228-1236
    de Kovel CGF, Syrbe S, …, Afawi Z, Klein KM, …, Pendziwiat M, Helbig I, …, Koeleman BPC
    (See online at https://doi.org/10.1001/jamaneurol.2017.1714)
  • The phenotypic spectrum of ARHGEF9 includes intellectual disability, focal epilepsy and febrile seizures. J Neurol. 2017 Jul;264(7):1421-1425
    Klein KM, Pendziwiat M, …, Kanaan M, Helbig I, Afawi Z; Israeli-Palestinian Epilepsy Family Consortium
    (See online at https://doi.org/10.1007/s00415-017-8539-3)
  • Mutations in PMPCB Encoding the Catalytic Subunit of the Mitochondrial Presequence Protease Cause Neurodegeneration in Early Childhood. Am J Hum Genet. 2018 Apr 5;102(4):557-573
    Vögtle FN, Brändl B, Larson A, Pendziwiat M, …, Helbig I
    (See online at https://doi.org/10.1016/j.ajhg.2018.02.014)
  • A Recurrent Missense Variant in AP2M1 Impairs Clathrin-Mediated Endocytosis and Causes Developmental and Epileptic Encephalopathy. Am J Hum Genet. 2019 May 2. pii: S0002-9297(19)30147-8
    Helbig I, Lopez-Hernandez T, …, Weber YG; EuroEPINOMICS-RES Consortium; GRIN Consortium
    (See online at https://doi.org/10.1016/j.ajhg.2019.04.001)
  • Biallelic VARS variants cause developmental encephalopathy with microcephaly that is recapitulated in vars knockout zebrafish. Nat Commun. 2019 Feb 12;10(1):708
    Siekierska A, Stamberger H, …, Helbig I; C4RCD Research Group; AR working group of the EuroEPINOMICS RES Consortium, Weckhuysen S, Francklyn C, Antonellis A, de Witte P, De Jonghe P
    (See online at https://doi.org/10.1038/s41467-018-07953-w)
  • Inclusion of hemimegalencephaly into the phenotypic spectrum of NPRL3 pathogenic variants in familial focal epilepsy with variable foci. Epilepsia. 2019 May 21
    Canavati C, Klein KM, Afawi Z, Pendziwiat M, Abu Rayyan, A, Kamal, L, Zahdeh, F, Qaysia, I, Helbig I, Kanaan, M
    (See online at https://doi.org/10.1111/epi.15665)
 
 

Additional Information

Textvergrößerung und Kontrastanpassung